Adalimumab Every Week
Phase 2
Adalimumab Every Week is one of 3 therapeutic programs targeting Chronic Plaque Psoriasis. It is currently in Phase 2.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
3 competitors in Chronic Plaque Psoriasis
#DrugCompanyPhaseTrials
1Cimzia
UCBPhase 3
Bimzelx
UCBPhase 3
Adalimumab Every Week
PPoitiers University Hospital
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Adalimumab Every Week. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]
- Company
- PPoitiers University Hospital